Neurodegenerative Diseases: New Hopes and Perspectives

被引:9
作者
Bhat, Mohammad Aadil [1 ]
Dhaneshwar, Suneela [2 ]
机构
[1] Amity Univ Uttar Pradesh, Amity Inst Pharm, Noida, UP, India
[2] Amity Univ Maharashtra, Amity Inst Pharm, Mumbai, Maharashtra, India
关键词
Alzheimer's disease; Parkinson's disease; Amyotrophic lateral sclerosis; Huntington's disease; Friedrich ataxia; Spinal muscular atrophy; SPINAL MUSCULAR-ATROPHY; TRANSGENIC MOUSE MODEL; AMYOTROPHIC-LATERAL-SCLEROSIS; PLACEBO-CONTROLLED TRIAL; FRONTOTEMPORAL LOBAR DEGENERATION; RECOMBINANT-HUMAN-ERYTHROPOIETIN; MUTANT HUNTINGTIN EXPRESSION; ETHYL-EICOSAPENTAENOIC ACID; STRIATAL CELL-DEATH; DOUBLE-BLIND TRIAL;
D O I
10.2174/1566524023666230907093451
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Alzheimer's disease, Parkinson's disease, Amyotrophic lateral sclerosis, Huntington's disease, and Friedrich ataxia are all incurable neurodegenerative diseases defined by the continuous progressive loss of distinct neuronal subtypes. Despite their rising prevalence among the world's ageing population, fewer advances have been made in the concurrent massive efforts to develop newer drugs. Recently, there has been a shift in research focus towards the discovery of new therapeutic agents for neurodegenerative diseases. In this review, we have summarized the recently developed therapies and their status in the management of neurodegenerative diseases.
引用
收藏
页码:1004 / 1032
页数:29
相关论文
共 275 条
[91]   AAV vector-mediated RNAi of mutant huntingtin expression is neuroprotective in a novel genetic rat model of Huntington's disease [J].
Franich, Nicholas R. ;
Fitzsimons, Helen L. ;
Fong, Dahna M. ;
Klugmann, Matthias ;
During, Matthew J. ;
Young, Deborah .
MOLECULAR THERAPY, 2008, 16 (05) :947-956
[93]   Haploinsufficiency of TBK1 causes familial ALS and fronto-temporal dementia [J].
Freischmidt, Axel ;
Wieland, Thomas ;
Richter, Benjamin ;
Ruf, Wolfgang ;
Schaeffer, Veronique ;
Mueller, Kathrin ;
Marroquin, Nicolai ;
Nordin, Frida ;
Huebers, Annemarie ;
Weydt, Patrick ;
Pinto, Susana ;
Press, Rayomond ;
Millecamps, Stephanie ;
Molko, Nicolas ;
Bernard, Emilien ;
Desnuelle, Claude ;
Soriani, Marie-Helene ;
Dorst, Johannes ;
Graf, Elisabeth ;
Nordstrom, Ulrika ;
Feiler, Marisa S. ;
Putz, Stefan ;
Boeckers, Tobias M. ;
Meyer, Thomas ;
Winkler, Andrea S. ;
Winkelman, Juliane ;
de Carvalho, Mamede ;
Thal, Dietmar R. ;
Otto, Markus ;
Brannstrom, Thomas ;
Volk, Alexander E. ;
Kursula, Petri ;
Danzer, Karin M. ;
Lichtner, Peter ;
Dikic, Ivan ;
Meitinger, Thomas ;
Ludolph, Albert C. ;
Strom, Tim M. ;
Andersen, Peter M. ;
Weishaupt, Jochen H. .
NATURE NEUROSCIENCE, 2015, 18 (05) :631-+
[94]   Congo red and protein aggregation in neurodegenerative diseases [J].
Frid, Petrea ;
Anisimov, Sergey V. ;
Popovic, Natalija .
BRAIN RESEARCH REVIEWS, 2007, 53 (01) :135-160
[95]   Neuroprotective effects of phenylbutyrate in the N171-82Q transgenic mouse model of Huntington's disease [J].
Gardian, G ;
Browne, SE ;
Choi, DK ;
Klivenyi, P ;
Gregorio, J ;
Kubilus, JK ;
Ryu, H ;
Langley, B ;
Ratan, RR ;
Ferrante, RJ ;
Beal, MF .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (01) :556-563
[96]   Comparative Analysis of the Effects of Neurotrophic Factors CDNF and GDNF in a Nonhuman Primate Model of Parkinson's Disease [J].
Garea-Rodriguez, Enrique ;
Eesmaa, Ave ;
Lindholm, Paeivi ;
Schlumbohm, Christina ;
Koenig, Jessica ;
Meller, Birgit ;
Krieglstein, Kerstin ;
Helms, Gunther ;
Saarma, Mart ;
Fuchs, Eberhard .
PLOS ONE, 2016, 11 (02)
[97]   Synthetic zinc finger repressors reduce mutant huntingtin expression in the brain of R6/2 mice [J].
Garriga-Canut, Mireia ;
Agustin-Pavon, Carmen ;
Herrmann, Frank ;
Sanchez, Aurora ;
Dierssen, Mara ;
Fillat, Cristina ;
Isalan, Mark .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (45) :E3136-E3145
[98]   Meclizine is neuroprotective in models of Huntington's disease [J].
Gohil, Vishal M. ;
Offner, Nicolas ;
Walker, James A. ;
Sheth, Sunil A. ;
Fossale, Elisa ;
Gusella, James F. ;
MacDonald, Marcy E. ;
Neri, Christian ;
Mootha, Vamsi K. .
HUMAN MOLECULAR GENETICS, 2011, 20 (02) :294-300
[99]  
Goldman S., 1998, Etiology of Parkinson's disease: Parkinson's disease and movement Disorders, P133
[100]   Deferiprone targets aconitase: Implication for Friedreich's ataxia treatment [J].
Goncalves S. ;
Paupe V. ;
Dassa E.P. ;
Rustin P. .
BMC Neurology, 8 (1)